---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-003203"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2026-04-24T23:59:59+00:00"
generated_at: "2026-05-15T04:11:50.950465+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences grants 100,000 restricted shares to Interim CEO James Parslow

## Summary
- Grant of 100,000 restricted shares to James Parslow, Interim CEO and CFO.
- 7,000 shares vest immediately; 31,000 vest on each of 1st, 2nd, 3rd anniversaries of April 21, 2026.
- All unvested shares accelerate upon a Change in Control.
- Award is under Amended and Restated Equity Incentive Plan; grant agreement filed as Exhibit 10.1.

## SEC filing metadata
- accession: 0001683168-26-003203
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2026-04-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316826003203/0001683168-26-003203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316826003203/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-003203
- JSON: https://secwatch.observer/filing/0001683168-26-003203.json
- Plain text: https://secwatch.observer/filing/0001683168-26-003203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.